Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Autologous Stem Cell Transplant in Fit Patients with Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Aung M. Tun, Seth Maliske, Yucai Wang, David James Inwards, Thomas M. Habermann, Ivana Micallef, Luis Porrata, Jonas Paludo, J. C. Villasboas, Allison C. Rosenthal, Mohamed A. Kharfan-Dabaja, Stephen M Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B Johnston

Blood (2023) 142 (Supplement 1): 2216.

https://doi.org/10.1182/blood-2023-185002

Published: 2023

Journal Articles

Treatment Pattern and Survival Outcome of Limited Stage Mantle Cell Lymphoma: A National Cancer Database Analysis in Pre-BTK Inhibitor Vs BTK Inhibitor Era

Jihao Zhou, Jacqueline F. Wang, Steven Ray Hwang, Jonas Paludo, Javier L. Munoz, David James Inwards, Allison C. Rosenthal, William Breen, Scott Lester, Stephen M Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, Yucai Wang

Blood (2023) 142 (Supplement 1): 1666.

https://doi.org/10.1182/blood-2023-177790

Published: 2023

Journal Articles

SEC61B Regulates Calcium Flux and Platelet Hyperactivity in Diabetes Mellitus

Yvonne X Kong, Rajan Rehan, Cesar L Moreno, Huiwen Zhao, David James, Michelle Cielesh, Grant Morahan, Sian Cartland, Mary Kavurma, Greg Neely, Matthew T. Rondina, James Weaver, Mark Larance, Freda H Passam

Blood (2023) 142 (Supplement 1): 680.

https://doi.org/10.1182/blood-2023-180297

Published: 2023

Journal Articles

Proteomics and Phospho-Proteomics Reveal Predictive Signatures of Response and Mechanisms of Resistance to Midostaurin Plus Chemotherapy in FLT3 Mutant Positive Acute Myeloid Leukemia

Luis Miguel Veiga Veiga Nobre, Salvatore Federico Pedicona, Arran Dokal, Andrea Arruda, Ryan Smith, Calum Greenhalgh, Francesca Patella, Pedro Casado-Izquierdo, Bela Wrench, Jane Theaker, Andrew Thompson, Mark D. Minden, John G. Gribben, David James Britton, Pedro Cutillas

Blood (2021) 138 (Supplement 1): 3462.

https://doi.org/10.1182/blood-2021-152379

Published: 2021

Journal Articles

Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma

Seth M Maliske, MD, Matthew J. Maurer, MS, Carrie A. Thompson, MD, Luis Porrata, MD, Ivana Micallef, MD, Rebecca L. King, MD, Sergei Syrbu, MD PhD, Brian K. Link, MD, Margarida Magalhaes Silverman, MD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, David James J Inwards, MD, Stephen M Ansell, MD PhD, James R. Cerhan, MD PhD, Patrick Johnston, MD PhD, Umar Farooq, MD

Blood (2019) 134 (Supplement_1): 2896.

https://doi.org/10.1182/blood-2019-124579

Published: 2019

Journal Articles

Rituximab and Obinutuzumab Induce Direct B-Cell Death Via B-Cell Receptor (BCR) Signaling, but Rituximab Elicits Stronger BCR-Derived Pro-Survival Signals Diminishing Apoptosis

Jennifer Edelmann, MD PhD, Arran Dokal, MSc, PhD, Karlheinz Holzmann, Dr. rer. nat., David James Britton, BSc, PhD, Emma Vilventhraraja, MSc, PhD, Ryan Jack Smith, PhD, Mark S Cragg, Prof, Andrejs Braun, PhD, Hartmut Döhner, MD, Pedro Cutillas, PhD, John G. Gribben, MD DSc

Blood (2019) 134 (Supplement_1): 1579.

https://doi.org/10.1182/blood-2019-128704

Published: 2019

Journal Articles

Erythrophagocytosis on the peripheral blood smear

Mark Grech, David James Camilleri

Blood (2019) 133 (3): 285.

https://doi.org/10.1182/blood-2018-10-879197

Published: 2019

Journal Articles

Anti-CD20 Monoclonal Antibodies Hijack the B-Cell Receptor Signaling Cascade Thereby Activating the NOTCH1 Signaling Pathway

Jennifer Edelmann, MD, David James Britton, BSc, PhD, Emma Vilventhraraja, MSc, PhD, Arran Dokal, MSc, PhD, Karlheinz Holzmann, Dr. rer. nat., Mark C Cragg, Andrejs Braun, PhD, Pedro Cutillas, PhD, John G. Gribben

Blood (2018) 132 (Supplement 1): 588.

https://doi.org/10.1182/blood-2018-99-116490

Published: 2018

Journal Articles

Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era

James Nathan Gerson, MD, Stefan Klaus Barta, MDMRCP,MS, Diego Villa, Alina S Gerrie, MD, Shaoying Li, MD, Jeffrey Medeiros, MD, Michael Wang, MD, Brian T. Hill, MD PhD, Yazeed Sawalha, MD, Francisco J. Hernandez-Ilizaliturri, MD, Shalin Kothari, MD, Julie M Vose, MD, Timothy S. Fenske, MD, Swapna Narayana Rao, MD, Kami J. Maddocks, MD, David A Bond, MD, Frederick Lansigan, MD, Timothy Burns, MD, Alexandra M Donovan, MD, Amitkumar Mehta, MD, Nishitha Reddy, MD MSCI, MBBS, Daniel J. Landsburg, MD, Martha Glenn, MD, David James Inwards, MD, Kay Ristow, Reem Karmali, MD MS, Jason Kaplan, MD, Elvira Umyarova, MD, Bhargavi Pulluri, MD, Jennifer E Amengual, MD, Jennifer Kimberly Lue, MD, Paolo Caimi, MD, Jonathon B Cohen, MDMS, Oscar Calzada, BS, Elizabeth Handorf, Jennifer Kelly Anderson, MD, Parv Chapani, Veronika Bachanova, MD PhD, Saurabh Rajguru, MD, Michael C Churnetski, BS, Catherine Diefenbach, Martin Bast, Alexandra E. Kovach, MD

Blood (2017) 130 (Supplement 1): 341.

https://doi.org/10.1182/blood.V130.Suppl_1.341.341

Published: 2017

Journal Articles

Vitamin D Insufficiency Is Associated with an Increased Risk of Early Clinical Failure in Follicular Lymphoma

Sean I. Tracy, MD PhD, Matthew J Maurer, MS, Thomas E. Witzig, MD, Matthew T. Drake, MD PhD, Stephen Ansell, MD PhD, Grzegorz S. Nowakowski, MD, David James Inwards, MD, Carrie A Thompson, MD, Patrick B. Johnston, MD PhD, Ivana Micallef, MD, Cristine Allmer, BS, William R. Macon, MD, George J Weiner, MD, Susan L. Slager, PhD, Thomas M. Habermann, MD, Brian K Link, MD, James R Cerhan, MD PhD

Blood (2016) 128 (22): 1104.

https://doi.org/10.1182/blood.V128.22.1104.1104

Published: 2016

Journal Articles

Sustained Natural Killer Cell Recovery Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation Predicts Survival in Non-Hodgkin's Lymphoma

Luis Porrata, MD, David James Inwards, MD, Stephen M Ansell, MD, PhD, Ivana Micallef, MD, Patrick B. Johnston, MD PhD, Wendy Nevala, Svetomir Markovic, MD PhD

Blood (2016) 128 (22): 4641.

https://doi.org/10.1182/blood.V128.22.4641.4641

Published: 2016

Journal Articles

Cardiac Outcomes in a Prospective Cohort of Adult Non-Hodgkin Lymphoma Survivors

Carrie A. Thompson, MD, Hongxiu Luo, Matthew J Maurer, MS, Cristine Allmer, Thomas M. Habermann, MD, Grzegorz S. Nowakowski, MD, David James Inwards, MD, Patrick B. Johnston, Luis F. Porrata, MD, Thomas E. Witzig, MD, Veronique Roger, MD, James R Cerhan, MD, PhD

Blood (2011) 118 (21): 2656.

https://doi.org/10.1182/blood.V118.21.2656.2656

Published: 2011

Journal Articles

Phase I Trial of a Novel Combination of An HDAC Inhibitor (LBH589) and An mTOR Inhibitor (RAD001) in Lymphoid and Plasma Cell Malignancies

Shaji Kumar, MD, Joseph R. Mikhael, MD, Betsy R. LaPlant, Joseph P. Colgan, MD, David James Inwards, MD, Patrick B. Johnston, Kristina Laumann, Ivana N. Micallef, MD, Grzegorz S. Nowakowski, Stephen M. Ansell, M.D., Ph.D., Kelly Curtis, MD, Angela Dispenzieri, MD, Martha Q Lacy, MD, Jose F. Leis, MD, PhD, Donald Northfelt, MD, Craig B. Reeder, MD, James L. Slack, MD, Thomas E. Witzig, MD

Blood (2011) 118 (21): 2682.

https://doi.org/10.1182/blood.V118.21.2682.2682

Published: 2011

Journal Articles

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Cell of Origin in Predicting Survival in Diffuse Large B-Cell Lymphoma,

Luis F. Porrata, MD, Kay M. Ristow, Joseph P. Colgan, MD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, David James Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2011) 118 (21): 3652.

https://doi.org/10.1182/blood.V118.21.3652.3652

Published: 2011

Journal Articles

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis and Survival in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,

Blood (2011) 118 (21): 3642.

https://doi.org/10.1182/blood.V118.21.3642.3642

Published: 2011

Journal Articles

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Wei Ding, MD, PhD, Tait D. Shanafelt, MD, Kari Rabe, MS, Timothy G. Call, MD, Clive S. Zent, MD, Neil Kay, MD, David James Inwards, MD, Deborah Bowen, Mark R. Litzow, MD, Susan L Slager, PhD, Susan Schwager, William J Hogan, MBBCh

Blood (2011) 118 (21): 4152.

https://doi.org/10.1182/blood.V118.21.4152.4152

Published: 2011

Journal Articles

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

Stephen M. Ansell, MD, PhD, Matthew J Maurer, MS, Steven C. Ziesmer, Susan L Slager, PhD, Thomas M. Habermann, MD, Brian K Link, MD, Thomas E. Witzig, MD, David James Inwards, MD, Joseph P. Colgan, MD, James R Cerhan, MD, PhD, Anne J. Novak, Ph.D.

Blood (2011) 118 (21): 429.

https://doi.org/10.1182/blood.V118.21.429.429

Published: 2011

Journal Articles

A Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)

Angela Dispenzieri, MD, Morie Abraham Gertz, MD, Martha Q Lacy, MD, Kristina Laumann, Betsy R. LaPlant, Shaji Kumar, MD, Francis K Buadi, M.D., Suzanne R. Hayman, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Stephen M Ansell, MD, Dennis A. Gastineau, MD, David James Inwards, MD, Ivana N. Micallef, MD, Luis F. Porrata, MD, Patrick B. Johnston, Mark R. Litzow, MD, Thomas E. Witzig, MD

Blood (2011) 118 (21): 3095.

https://doi.org/10.1182/blood.V118.21.3095.3095

Published: 2011

Journal Articles

Risk of Transformation of Follicular Lymphoma to High Grade Lymphoma After Radioimmunotherapy: A Prospective Observational Single Institutional Experience

Brian L. Burnette, MD, Gregory Wiseman, MD, Thomas M. Habermann, MD, William R Macon, MD, Stephen M. Ansell, MD, PhD, David James Inwards, MD, Ivana N. Micallef, MD, Patrick B. Johnston, Kay M. Ristow, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD

Blood (2011) 118 (21): 1572.

https://doi.org/10.1182/blood.V118.21.1572.1572

Published: 2011

Journal Articles

Prior Rituximab Exposure Does Not Appear to Affect Time to Treatment Failure After Radioimmunotherapy

Brian L. Burnette, MD, Gregory Wiseman, MD, Thomas M. Habermann, MD, Stephen M. Ansell, MD, PhD, Luis F. Porrata, MD, David James Inwards, MD, Patrick B. Johnston, Ivana Micallef, William R Macon, MD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski

Blood (2011) 118 (21): 1640.

https://doi.org/10.1182/blood.V118.21.1640.1640

Published: 2011

NARROW

Autologous Stem Cell Transplant in Fit Patients with Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Treatment Pattern and Survival Outcome of Limited Stage Mantle Cell Lymphoma: A National Cancer Database Analysis in Pre-BTK Inhibitor Vs BTK Inhibitor Era

SEC61B Regulates Calcium Flux and Platelet Hyperactivity in Diabetes Mellitus

Proteomics and Phospho-Proteomics Reveal Predictive Signatures of Response and Mechanisms of Resistance to Midostaurin Plus Chemotherapy in FLT3 Mutant Positive Acute Myeloid Leukemia

Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma

Rituximab and Obinutuzumab Induce Direct B-Cell Death Via B-Cell Receptor (BCR) Signaling, but Rituximab Elicits Stronger BCR-Derived Pro-Survival Signals Diminishing Apoptosis

Erythrophagocytosis on the peripheral blood smear

Anti-CD20 Monoclonal Antibodies Hijack the B-Cell Receptor Signaling Cascade Thereby Activating the NOTCH1 Signaling Pathway

Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era

Vitamin D Insufficiency Is Associated with an Increased Risk of Early Clinical Failure in Follicular Lymphoma

Sustained Natural Killer Cell Recovery Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation Predicts Survival in Non-Hodgkin's Lymphoma

Cardiac Outcomes in a Prospective Cohort of Adult Non-Hodgkin Lymphoma Survivors

Phase I Trial of a Novel Combination of An HDAC Inhibitor (LBH589) and An mTOR Inhibitor (RAD001) in Lymphoid and Plasma Cell Malignancies

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Cell of Origin in Predicting Survival in Diffuse Large B-Cell Lymphoma,

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis and Survival in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

A Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)

Risk of Transformation of Follicular Lymphoma to High Grade Lymphoma After Radioimmunotherapy: A Prospective Observational Single Institutional Experience

Prior Rituximab Exposure Does Not Appear to Affect Time to Treatment Failure After Radioimmunotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only